Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2001
09/27/2001WO2001070233A2 Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
09/27/2001WO2001070231A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
09/27/2001WO2001070230A2 Compounds with 5-ht activity useful for controlling visual field loss
09/27/2001WO2001070229A1 Thrombin inhibitors
09/27/2001WO2001070226A1 Novel processes for preparing torsemide intermediate
09/27/2001WO2001070224A2 Rilmenidine dressing and method for preparing same
09/27/2001WO2001070223A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
09/27/2001WO2001070222A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
09/27/2001WO2001070219A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
09/27/2001WO2001070218A1 Method for treating congestive heart failure
09/27/2001WO2001070211A2 L-arginine and phosphodiesterase (pde) inhibitor synergism
09/27/2001WO2001070209A2 Mono- and disaccharides for the treatment of nitric oxide related disorders
09/27/2001WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
09/27/2001WO2001070199A1 Matrices containing nitric oxide donors and reducing agents and their use
09/27/2001WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy
09/27/2001WO2001070174A2 Vegf-modulated genes and methods employing them
09/27/2001WO2001070130A2 Compositions derived from modiolus modiolus and methods for making and using same
09/27/2001WO2001070031A1 Opioid growth factor modulates angiogenesis
09/27/2001WO2001062705A8 Aminoalcohol derivatives
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2001032654A3 Novel heterocyclic compounds and their use as medicines
09/27/2001WO2001030754A3 Micro-cluster liquids and methods of making and using them
09/27/2001WO2001019829A3 Pyrazolopyrimidines as therapeutic agents
09/27/2001WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs
09/27/2001WO2001017558A3 Novel uses of mammalian ccr6 receptors and related reagents
09/27/2001WO2001016170A3 Card proteins involved in cell death regulation
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001US20010025108 Thrombosis diseases
09/27/2001US20010025057 Containing nitric oxide donar containing nitroglycerin, glycol dinitrate, isopropyl nitrate, glyceryl-1,3-dinitrate, glyceryl-1,2-dinitrate, butane-1,2,4-triol-trinitrate, erythrityl teteranitrate, pentaerithrityl tetetranitrate etc.
09/27/2001US20010025054 Mono or dinitro substituted phenyl-alkylene-amide-alkylene-amino-alkyelene-aryl or heteroaryl derivatives, useful for prophylaxis and/or treatment of arrhythmia and ischaemic rhythm disorders
09/27/2001US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives
09/27/2001US20010025044 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli
09/27/2001US20010025041 Amidino protease inhibitors
09/27/2001US20010025039 Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity
09/27/2001US20010025036 Modifying the structure of a 1alpha-hydroxylated vitamin D compound to increase its in vivo activity by altering the conformational equilibrium of the A-ring to favor a chair conformation that presents 1alphahydroxy in axial orientation
09/27/2001US20010025029 Novel stromelysin inhibitors
09/27/2001US20010024666 Composition for and method of reducing low density lipoprotein cholesterol concentration
09/27/2001US20010024664 Alzheimer's diseases; central nervous system disorders; antiinflammatory agent; solvent extraction from plants
09/27/2001US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release
09/27/2001US20010024650 Artery - and vein-specific proteins and uses therefor
09/27/2001US20010024647 Single chain variable region immunoglobulin (ScFv) fragment antibody that binds selectively to the active conformation of human von Willebrand Factor (vWF) and the antibody inhibits the binding of vWF to platelets
09/27/2001US20010024642 A chewing gum that includes a gum center and a coating that substantially surrounds the center, comprises at least 50% by weight of chewing gum, the coating includes medicine; chewing the gum, causes the drug release, in patients buccal cavity
09/27/2001US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue
09/27/2001US20010024637 Novel compositions for use in embolizing blood vessels
09/27/2001DE10014645A1 New amidino-aryl substituted biphenyl derivatives and analogs as Factor Xa inhibitors, are useful for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation, apoplexy or angina pectoris
09/27/2001CA2404216A1 Novel polypeptides, and nucleic acids encoding the same
09/27/2001CA2404115A1 The use of peg-hirudin as an anticoagulant agent in the extracorporeal treatment of blood
09/27/2001CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001CA2403828A1 Inhibitors of p38
09/27/2001CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001CA2403818A1 Matrices containing nitric oxide donors and reducing agents and their use
09/27/2001CA2403809A1 Angiogenesis - associated proteins, and nucleic acids encoding the same
09/27/2001CA2403808A1 Thiepino [3,2-b] dihydropyridines and related compositions and methods
09/27/2001CA2403805A1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/27/2001CA2403804A1 Vegf-modulated genes and methods employing them
09/27/2001CA2403795A1 Osteocalcin promoter directed adenovirus replicaton for therapy
09/27/2001CA2403714A1 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
09/27/2001CA2403671A1 Compositions derived from modiolus modiolus and methods for making and using same
09/27/2001CA2403558A1 Thrombin inhibitors
09/27/2001CA2403447A1 Peptide derivative
09/27/2001CA2403444A1 Restenosis treatment
09/27/2001CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand
09/27/2001CA2403434A1 Human gata-5 transcription factor
09/27/2001CA2403382A1 Novel processes for preparing torsemide intermediate
09/27/2001CA2403075A1 Mono- and disaccharides for the treatment of nitric oxide related disorders
09/27/2001CA2402763A1 Proteases
09/27/2001CA2402747A1 G-protein associated molecules
09/27/2001CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency
09/27/2001CA2402572A1 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity
09/27/2001CA2402414A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
09/27/2001CA2401984A1 Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors
09/27/2001CA2401908A1 Amorphous torasemide modification
09/27/2001CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
09/27/2001CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
09/27/2001CA2401728A1 Difluorobutyric acid metalloprotease inhibitors
09/27/2001CA2401368A1 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
09/27/2001CA2400637A1 Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
09/27/2001CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001CA2399985A1 Compounds with 5-ht activity useful for controlling visual field loss
09/27/2001CA2374073A1 Novel polypeptides and nucleic acids encoding same
09/27/2001CA2364268A1 Di-substituted iminoheterocyclic compounds
09/26/2001EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof
09/26/2001EP1136503A1 Novel physiologically active substance, process for producing the same and utilization thereof
09/26/2001EP1136488A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
09/26/2001EP1136482A1 2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
09/26/2001EP1136474A1 1-Acetyl-5-bromo-4,6-dimethyl-indoline
09/26/2001EP1136083A1 Gene therapy for cardiomyopathy
09/26/2001EP1136078A2 Combination of angiotensin converting enzyme inhibitor and side- effect-reduced amount of aldosterone antagonist
09/26/2001EP1136073A1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
09/26/2001EP1135991A2 Oil composition and use thereof
09/26/2001EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3)
09/26/2001EP1135534A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases
09/26/2001EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies
09/26/2001EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/26/2001EP1135484A2 Gtpase associated proteins
09/26/2001EP1135477A1 Humanized monoclonal antibodies
09/26/2001EP1135413A2 Proteins that bind angiogenesis-inhibiting proteins, compoisitions and methods of use thereof
09/26/2001EP1135406A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
09/26/2001EP1135391A1 Novel triazolo(4,5-d)pyrimidine compounds
09/26/2001EP1135381A1 Eletriptan hydrobromide monohydrate
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 1595